Aclarion (ACON)
(Delayed Data from NSDQ)
$9.40 USD
+1.20 (14.63%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $9.39 -0.01 (-0.11%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ACON 9.40 +1.20(14.63%)
Will ACON be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ACON based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ACON
AMN Healthcare Services (AMN) Tops Q2 Earnings and Revenue Estimates
Are Medical Stocks Lagging Boston Scientific (BSX) This Year?
ACON: What are Zacks experts saying now?
Zacks Private Portfolio Services
Aclarion (ACON) Upgraded to Buy: Here's What You Should Know
Agilon Health (AGL) Reports Q3 Loss, Lags Revenue Estimates
Other News for ACON
Is ACON likely to continue higher? Reversal New Highs Setup shows up after soaring 7.52%
12 Health Care Stocks Moving In Friday's Pre-Market Session
Ascendiant Sticks to Their Buy Rating for Aclarion, Inc. (ACON)
ACON Stock: Analyst Boosts Price Target While Maintaining Buy Rating | ACON Stock News
Upper Bollinger Band Walk appears for ACON after 0.57% move